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Abstract
Background: Analysis of biomedical research and publications in a country or group of countries
is used to monitor research progress and trends. This study aims to assess the performance of
biomedical research in the Arab world during 2001–2005 and to compare it with other Middle
Eastern non-Arab countries.
Methods:  PubMed and Science Citation Index Expanded (SCI-expanded) were searched
systematically for the original biomedical research publications and their citation frequencies of 16
Arab nations and three non-Arab Middle Eastern countries (Iran, Israel and Turkey), all of which
are classified as middle or high income countries.
Results: The 16 Arab countries together have 5775 and 14,374 original research articles listed by
PubMed and SCI-expanded, respectively, significantly less (p < 0.001) than the other three Middle
Eastern countries (25,643 and 49,110). The Arab countries also scored less when the data were
normalized to population, gross domestic product (GDP), and GDP/capita. The publications from
the Arab countries also have a significantly lower (p < 0.001) citation frequency.
Conclusion: The Arab world is producing fewer biomedical publications of lower quality than
other Middle Eastern countries. Studies are needed to clarify the causes and to propose strategies
to improve the biomedical research status in Arab countries.
Background
The quality and the quantity of biomedical publications is
used to asses the scientific activities of universities and
research centres in individual countries [1], groups of
countries [2,3], and even continents [4]. Such analyses
make use of scientific bibliographic databases, e.g.
PubMed and Science Citation Index Expanded (SCI-
expanded). Pubmed is freely available http://
www.ncbi.nlm.nih.gov/sites/entrez and widely used. It
contains records from > 5000 biomedical journals. SCI-
expanded http://scientific.thomson.com/products/sci/,
on the other hand, contains bibliographic information
from all fields of science, including biomedical research,
and covers about 6650 journals in all field of science, but
it requires a subscription.
The contribution of the Islamic civilization, of which the
Arabs were a central component, to medicine in the Mid-
dle Ages is well recognised. Arabic was considered the lan-
guage of sciences and Avicenna's "The Canon of Medicine"
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was considered the main textbook of medicine in Europe
for many centuries. Nowadays, the Arab countries are
counted among the developing countries and have a com-
bined estimated population of about 315 million. The
Arab populations share a language, and most of them
share a religion, culture and historical background. Thus,
they are frequently regarded as one unit despite the differ-
ences in wealth and population size. Over the last four
decades, living standards in most Arab countries have
risen, especially those with oil-based economies, the
number of undergraduate and postgraduate medical insti-
tutions have increased, and health services have
improved. This should have been accompanied by
increases in scientific research output. Qualitative and
quantitative evaluation of biomedical research publica-
tion in the Arab countries is essential for monitoring and
improving this activity.
Published studies assessing biomedical research output of
Arab countries have been mainly quantitative [1,2,5,6].
Therefore, this study analyses both the quantity and qual-
ity of biomedical publications of original research articles
in Arab countries with high or middle income (World
Bank classification), and compares the Arab countries
with non-Arab Middle Eastern countries of similar
income. This could help in putting the publication activi-
ties in the Arab countries in perspective.
Methods
Sixteen Arab countries of high or middle income (World
Bank classification) were included: Morocco, Algeria,
Tunisia, Libya, Egypt, Sudan, Lebanon, Jordan, Syria, Iraq,
Saudi Arabia, Qatar, Kuwait, United Arab Emirates, Oman
and Bahrain. Other Arab countries in the region were
excluded because of their low income: Yemen, Comoros,
Djibouti, Somalia, Eritrea and Mauritania. Iran, Israel and
Turkey were included as non-Arab countries in the region.
Two scientific bibliographic databases, PubMed and SCI-
expanded, were selected because they implement accepta-
ble international standards. They were searched for the
number of "original research" articles published between
January 1st, 2001 and December 31st, 2005 and affiliated
to the countries being studied. We have chosen to report
only original articles because they represent the research
activities. All searches were completed within one day on
06th February 2008 to avoid bias due to the daily update
of the databases.
Search of PubMed was carried out in two steps:
1- In the search field, the name of the country was queried
using the sensitive query described by Tadmouri & Bissar-
Tadmouri [7]. For example, for United Arab Emirates we
used "United Arab Emirates" OR UAE OR "Emirats Arabes
Unis."
2- The limits facility of PubMed was used to obtain only
original research articles, as follows: from January 1st 2001
to December 31st 2005, clinical trial, meta-analysis, ran-
domised controlled trial, clinical trial Phase I, clinical trial
Phase II, clinical trial Phase III, clinical trial Phase IV, com-
parative studies, controlled clinical trial, evaluation stud-
ies, multi-centre studies, research support, non U S Gov't,
twin studies, validation studies, English, French.
SCI-expanded was searched as follows:
1- SCI-expanded was queried for biomedical research arti-
cles affiliated to the afore-mentioned countries. In the
advanced search field, SCI sensitive search field tag "cu"
was used to search for the name of the country, e.g. cu =
Egypt retrieves all the publications affiliated to Egypt.
2- The search was limited to the five-year period from Jan-
uary 1st 2001 to December 31st 2005.
3- The search was limited to original research articles.
Meeting abstracts, reviews, letters, editorials, corrections,
reprints, news items, biographical-items and book reviews
were excluded.
4- Non-biomedical articles were excluded by screening the
types of articles according to subject. Therefore, subjects
such as medicine, surgery, paediatrics, pharmacology,
physiology, pathology, infectious diseases, parasitology,
microbiology, biochemistry and laboratory medicine,
molecular and cell biology, genetics, radiology, neurol-
ogy, ophthalmology, dermatology, orthopaedics and
rheumatology, and public health were used. Subjects such
as engineering, energy, physics, chemical chemistry, tele-
communication, fishing, water, and transportation were
excluded.
6- The article types were rechecked according to journal
source. This is an automatic function of the database that
ensures that all the articles are published in biomedical
journals.
7- The database then generates a count of the total
number of original articles, the total citations, and the
value of the h-index (highly cited index). The six-year
impact factor was defined as the total number of citations
found on the search date divided by the number of articles
being studied. The h-index was originally developed as a
measure of qualifying research performance [8,9]. It is
defined as the number of items, h, which have at least h
citations (for example: h-index of 12 means that there are
12 items that have 12 citations or more).
The raw results from each country were normalized by the
average of that country's population (2000–2005, the
population division of the Department of Economic andBMC Medical Research Methodology 2009, 9:26 http://www.biomedcentral.com/1471-2288/9/26
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Social Affairs of the United Nations Secretariat, World
Population Prospects, http://esa.un.org/unpp/), and the
gross domestic product (GDP) and GDP/capita (2003–
2006, World Bank, http://web.worldbank.org/WBSIT-
TERL/DATASTATISTICS/
0,,content20535285~menK:1192694~pagePK:64133150
~4133175~theS itePK:239419,00.html).
Biomedical research performance was assessed by the fol-
lowing criteria:
1- the number of the original research articles indexed
in PubMed and SCI;
2- the h-index;
3- the six-year impact factor (citations frequency);
4- the number of publications in the top medical jour-
nals (impact factor >15 according to Science Edition of
the Journal Citation Reports, year 2007). The top jour-
nals in alphabetical order were the following: Cancer
Cell, Cancer Journal for Clinicians, Cell, Cell Metabolism,
Genes & Development, Immunity, Journal of the American
Medical, Journal of Clinical Investigation, Journal of the
National Cancer Institute, Lancet, Nature, Nature Bio-
technology, Nature Cell Biology, Nature Genetics, Nature
Immunology, Nature Medicine, New England Journal of
Medicine, and Science.
Statistical analysis was performed with SPSS 12.0.1 for
Windows (SPSS Inc., Chicago, lL, USA). The differences
between groups were compared using the non-parametric
Mann-Whitney U-test or Chi-square (χ2) test, as appropri-
ate. A p-value < 0.05 was considered significant.
Results
The 16 Arab countries included in the study have a total
population of 267.1 million and a GDP of $1082 billion.
The other three Middle Eastern countries have 158.2 mil-
lion inhabitants and a GDP of $749 billion.
According to SCI-expanded, the Arab countries produced
14,374 original biomedical publications during 2001–
2005, which is less than 30% of those produced by the
other three Middle Eastern countries (49,110 articles);
according to PubMed, they produced 5775 articles, which
is less than 23% of those produced by the three non-Arab
countries (25,634 article) (p < 0.001, Table 1). PubMed
indexes the address of only the first author, whereas SCI
indexes the addresses of all coauthors. That could explain
the difference in the numbers of articles recovered by the
two databases.
Table 1: The total number of original research articles from 16 Arab countries and three non-Arab Middle Eastern countries published 
in PubMed and SCI-expanded during 2001–2005 and their citations frequencies (impact factors).
Country Number of articles in Impact factor* h-index
PubMed SCI high impact journals
Iran 1910 2965 5 4.96 31
Israel 13637 20504 369 11.89 110
Turkey 10087 25641 38 4.5 56
Total 25643 49110 412 7.1**
Algeria 84 254 5 9.19 21
Bahrain 51 158 0 2.61 8
Egypt 1180 3214 9 5.78 37
Iraq 64 138 3 3.84 11
Jordan 464 822 5 3.7 20
Kuwait 632 1207 8 4.78 24
Lebanon 447 965 7 6.14 31
Libya 19 87 0 3.18 9
Morocco 346 1267 6 3.74 23
Oman 134 436 3 3.43 14
Qatar 50 166 0 3.2 9
Saudi Arabia 999 3134 22 4.26 38
Syria 58 130 0 6.01 13
Sudan 134 265 3 7.18 18
Tunisia 592 1376 9 4.77 26
UAE*** 521 755 3 5.93 26
Total 5775 14374 83 4.9**
* Six-year impact factor, 2002–2007
**Average
***UAE: United Arab EmiratesBMC Medical Research Methodology 2009, 9:26 http://www.biomedcentral.com/1471-2288/9/26
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The Arab countries also have a significantly lower publica-
tion rate than the other Middle Eastern countries when
the number of publications is normalized to population,
GDP, and GDP/capita (Table 2, Figure 1, 2). Jordan
topped the Arab countries when the data were normalized
to GDP, and Kuwait came first when data were normal-
ized to population. Egypt ranked first when the number of
publications was normalized to GDP/capita (Figure 2).
The number of publications in top medical journals, cita-
tion frequency (six-year impact factor), and the h-index
were all significantly higher in the three Middle Eastern
countries (p < 0.001) (Table 1, 2).
Discussion
We compared the biomedical research performance in the
Arab world with that in non-Arab Middle Eastern coun-
tries. We show that Arab countries are lagging behind in
the number of original biomedical research publications,
publications in top medical journals, and citation fre-
quencies (six-year impact factor and h-index). They also
lag behind when the number of publications is normal-
ized to population, GDP, and GDP/capita.
Several studies discussed the reasons leading to the pau-
city of medical research and biomedical publications in
the Arab world. Tadmouri & Bissar-Tadmouri [2] sug-
gested that the regional conflicts have been a major reason
for the stagnation of medical publications in Arab coun-
tries. However, the other Middle Eastern countries have
also been exposed to considerable instability and regional
conflicts. Lack of freedom, democracy and funding, as
well as brain drain and the difficulty of publishing
research of local interest in high impact journals, all con-
tribute to the low performance of biomedical research in
the Arab world [10,11]. All these factors have to be taken
into consideration if the governments of the Arab coun-
tries wish to improve the status of their biomedical
research.
Previous studies addressed the issue of biomedical publi-
cations in the Arab world as a whole or in individual
countries [1-3,5,6]. Shaban and Abu-Zidan reported that
between 1987 and 2001 Egypt and Saudi Arabia had the
most biomedical publications among the Arab countries
[6]. Our results are similar, as these two countries had the
highest number of original research publications in the
Arab world. Also, Kuwait was reported to have the largest
number of publications when normalized to the popula-
tion, and Jordan came first when its data were normalized
to GDP [6]. Here we report similar findings, but add that
Egypt ranked first in the rate of publications per GDP/cap-
ita for 2001–2005, which is in line with the results of Tad-
mouri & Bissar-Tadmouri for 1988 and 2002 [2].
The total number of original biomedical research articles indexed in SCI-Expanded and affiliated to 16 Arab nations and three  non-Arab Middle Eastern countries per million population (dark grey) and per $100 million GDP (light grey) Figure 1
The total number of original biomedical research articles indexed in SCI-Expanded and affiliated to 16 Arab 
nations and three non-Arab Middle Eastern countries per million population (dark grey) and per $100 million 
GDP (light grey).BMC Medical Research Methodology 2009, 9:26 http://www.biomedcentral.com/1471-2288/9/26
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Therefore, we conclude that Egypt, Kuwait, Jordan and
Saudi Arabia are leading the Arab world in biomedical
research.
Some studies have indicated that raw counts of publica-
tions can be misleading and that counts should be nor-
malized to indicators such as population and GDP [6].
Other studies point out that GDP-normalized bibliomet-
ric data could also be misleading, especially in the case of
developing countries [2]. Some authors advocate the use
of citations as an indication of the quality of research per-
formance [5,12], but others indicated the shortfalls of
such an approach [13,14]. Also, false-positive and false-
negative results are unavoidable when using scientific bib-
liographic databases [15,16]. We tried to overcome some
of these problems when assessing the quantity and quality
of biomedical research publications by specifically select-
ing the original research articles indexed in two highly
prestigious databases (SCI and PubMed) and presenting
the data both in raw form and after normalization, as well
as using two indicators of citation frequency (six-year
impact factor and the h-index). Furthermore, we also
counted original research articles published in high-
impact biomedical journals as a different indicator of
research performance.
Nevertheless, it is important to stress that one shortcom-
ing of comparing the Arab countries with other Middle
The number of SCI-indexed original biomedical research publications from 16 Arab and three non-Arab Middle Eastern coun- tries per GPD/capita (US $) Figure 2
The number of SCI-indexed original biomedical research publications from 16 Arab and three non-Arab Mid-
dle Eastern countries per GPD/capita (US $).BMC Medical Research Methodology 2009, 9:26 http://www.biomedcentral.com/1471-2288/9/26
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Eastern countries is that research resources are usually
more effectively used when they are pooled in a single
country rather than divided among many. Therefore, this
study has the limitations that are inherent in the different
bibliometric methods, and the results should be inter-
preted in this context. Despite these limitations, our study
clearly highlights the modesty of biomedical research per-
formance in the Arab world.
Citation frequency is an important tool in the evaluation
of research performance, as it correlates with the peer-
evaluation of research impact and quality [8,9]. The
impact factor and h-index make it easier to gain more
information about the publications and trends of individ-
uals, institutes, and countries. Arab countries should pay
attention to the low citation frequencies of their research
publications. Medical schools and research institutes have
to set short and long term plans to improve the impact of
the local research. Arab countries should benefit from the
experience of other countries that have equivalent eco-
nomic resources but outperform them in biomedical
research.
Conclusion
This study shows that Arab countries are not producing
enough biomedical publications compared to other Mid-
dle Eastern countries with similar economic conditions.
Action is necessary to improve the status of biomedical
research in Arab countries. Studies are needed to clarify
the causes and to propose strategies to improve the bio-
medical research status in the Arab world.
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Table 2: Comparison of original biomedical research performance in 16 Arab countries and three non-Arab Middle Eastern countries 
(2001–2005)
Countries P-Value
Arab Middle Eastern
Number of articles according to SCI-expanded 14374.0 49110.0 < 0.001
Number of articles according to PubMed 5775.0 25634.0 < 0.001
Number of publications in the high-impact journals 83.0 412.0 < 0.001
Annual publication rate per one million population 10.8 62.1 0.029
Annual publication rate per one billion (US$) GPD 2.7 13.1 0.001
Annual publication rate per GPD/capita 0.7 2.1 < 0.001